Tang Xinyu, Wahed Abdus S
Tang Biostatistics Program, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Stat Biosci. 2015 May;7(1):1-18. doi: 10.1007/s12561-013-9089-6.
The proportional hazards model is widely used in survival analysis to allow adjustment for baseline covariates. The proportional hazard assumption may not be valid for treatment regimes that depend on intermediate responses to prior treatments received, and it is not clear how such a model can be adapted to clinical trials employing more than one randomization. Besides, since treatment is modified post-baseline, the hazards are unlikely to be proportional across treatment regimes. Although Lokhnygina and Helterbrand (Biometrics 63: 422-428, 2007) introduced the Cox regression method for two-stage randomization designs, their method can only be applied to test the equality of two treatment regimes that share the same maintenance therapy. Moreover, their method does not allow auxiliary variables to be included in the model nor does it account for treatment effects that are not constant over time. In this article, we propose a model that assumes proportionality across covariates within each treatment regime but not across treatment regimes. Comparisons among treatment regimes are performed by testing the log ratio of the estimated cumulative hazards. The ratio of the cumulative hazard across treatment regimes is estimated using a weighted Breslow-type statistic. A simulation study was conducted to evaluate the performance of the estimators and proposed tests.
比例风险模型在生存分析中被广泛应用,以对基线协变量进行调整。对于依赖于对先前接受治疗的中间反应的治疗方案,比例风险假设可能无效,并且尚不清楚这样的模型如何能适用于采用不止一次随机化的临床试验。此外,由于治疗是在基线后进行调整的,不同治疗方案的风险不太可能成比例。尽管Lokhnygina和Helterbrand(《生物统计学》63: 422 - 428, 2007)介绍了用于两阶段随机化设计的Cox回归方法,但其方法仅能用于检验共享相同维持治疗的两种治疗方案的相等性。此外,他们的方法不允许在模型中纳入辅助变量,也未考虑随时间变化不恒定的治疗效果。在本文中,我们提出了一个模型,该模型假设在每个治疗方案内协变量成比例,但不同治疗方案之间不成比例。通过检验估计的累积风险的对数比来进行不同治疗方案之间的比较。使用加权Breslow型统计量估计不同治疗方案的累积风险比。进行了一项模拟研究以评估估计量和所提出检验的性能。